HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M A Menter Selected Research

tildrakizumab

10/2022Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5-year data from reSURFACE 1 and reSURFACE 2.
12/2020Clearance of head and neck involvement in plaque psoriasis with tildrakizumab treatment in the phase 3 reSURFACE 1 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M A Menter Research Topics

Disease

5Psoriasis (Pustulosis Palmaris et Plantaris)
10/2022 - 10/2015
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2022
1Psoriatic Arthritis
11/2021
1Ankylosing Spondylitis
11/2021
1Neoplasms (Cancer)
11/2021
1Herpes Zoster
10/2015

Drug/Important Bio-Agent (IBA)

2tildrakizumabIBA
10/2022 - 12/2020
1secukinumabIBA
11/2021
1Janus KinasesIBA
06/2016
1CytokinesIBA
06/2016
1baricitinibIBA
06/2016
1Janus Kinase InhibitorsIBA
10/2015
1tofacitinibIBA
10/2015
1Prostaglandins AIBA
10/2015

Therapy/Procedure

1Biological Therapy
11/2021